Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsActos

    Actos

    Jump to

    • Bullish on Glenmark, Ipca Labs among midcaps: Antique

      In an interview to CNBC-TV18, Anmol Ganjoo of Antique Broking share outlook on the pharmaceutical space and trading strategies for various stocks in the sector. He is bullish on Glenmark and Ipca laboratories from the midcap pharma space.

    • Torrent Pharma gains on USFDA nod for generics of Actos

      Torrent Pharmaceuticals gained more than one percent intraday on Friday as the company received approval from US FDA for generics of Actos and Actoplus Met.

    • Aurobindo gets USFDA nod for a copy of diabetes drug Actos

      Drug maker Aurobindo Pharma has got final approval from US Food and Drugs Administration (FDA) to manufacture and market Pioglitazone tablets in 15mg, 30mg and 45mg strength, and its earlier tentatively approved Pioglitazone Hydrochloride + Metformin Hydrochloride tablets in 15mg (base)/500mg and 15mg (base)/850mg strengths.

    • Ranbaxy launches generic diabetes drug in US

      Ranbaxy Laboratories said it launched a generic version of Takeda Pharmaceutical Co Ltd' big-selling diabetes drug Actos in the United States.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347